Published in Neuroscience on December 15, 2007
Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol (2009) 2.98
Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke (2011) 2.26
Limb remote ischemic postconditioning protects against focal ischemia in rats. Brain Res (2009) 1.26
Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One (2008) 1.25
Preconditioning the brain: moving on to the next frontier of neurotherapeutics. Stroke (2012) 1.15
Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog Neurobiol (2014) 1.13
Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol (2011) 1.08
Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning. Int Neurourol J (2010) 1.07
Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke (2010) 1.05
The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS One (2012) 1.01
CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke. J Neuroinflammation (2012) 0.99
Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res (2010) 0.96
Remote ischemic conditioning: from bench to bedside. Front Physiol (2012) 0.94
The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in Rats. Transl Stroke Res (2010) 0.94
Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia-reperfusion injury. Inflamm Res (2010) 0.90
Postoperative neurocognitive dysfunction in patients undergoing cardiac surgery after remote ischemic preconditioning: a double-blind randomized controlled pilot study. PLoS One (2013) 0.89
Pharmacologic preconditioning: translating the promise. Transl Stroke Res (2010) 0.89
Ischemic preconditioning and remote ischemic preconditioning have protective effect against cold ischemia-reperfusion injury of rat small intestine. Pediatr Surg Int (2010) 0.86
Remote ischemic preconditioning protects neurocognitive function of rats following cerebral hypoperfusion. Med Sci Monit (2011) 0.86
Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage. Neurosurgery (2014) 0.86
The role of the ubiquitin proteasome system in ischemia and ischemic tolerance. Neuroscientist (2009) 0.86
Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment. Neurotherapeutics (2015) 0.85
Seizure preconditioning and epileptic tolerance: models and mechanisms. Int J Physiol Pathophysiol Pharmacol (2009) 0.85
Should the STAIR criteria be modified for preconditioning studies? Transl Stroke Res (2013) 0.83
Putative role of ischemic postconditioning in a rat model of limb ischemia and reperfusion: involvement of hypoxia-inducible factor-1α expression. Braz J Med Biol Res (2014) 0.83
Peripheral vascular disease as remote ischemic preconditioning, for acute stroke. Clin Neurol Neurosurg (2013) 0.82
Possible involvement of α1-adrenergic receptor and K(ATP) channels in cardioprotective effect of remote aortic preconditioning in isolated rat heart. J Cardiovasc Dis Res (2010) 0.82
Oxidative stress and hypoxia-induced factor 1α expression in gastric ischemia. World J Gastroenterol (2011) 0.81
Remote ischemic postconditioning protects against gastric mucosal lesions in rats. World J Gastroenterol (2014) 0.81
Non-invasive remote limb ischemic postconditioning protects rats against focal cerebral ischemia by upregulating STAT3 and reducing apoptosis. Int J Mol Med (2014) 0.80
Limb remote ischemic postconditioning protects cerebral ischemia from injury associated with expression of HIF-1α in rats. BMC Neurosci (2015) 0.80
A critical review of mechanisms regulating remote preconditioning-induced brain protection. J Appl Physiol (1985) (2015) 0.79
Full steam ahead with remote ischemic conditioning for stroke. Transl Stroke Res (2014) 0.79
Remote limb ischemic conditioning enhances motor learning in healthy humans. J Neurophysiol (2015) 0.79
Using hormetic strategies to improve ischemic preconditioning and postconditioning against stroke. Int J Physiol Pathophysiol Pharmacol (2013) 0.78
Protective effect of remote limb ischemic perconditioning on the liver grafts of rats with a novel model. PLoS One (2015) 0.78
Protective effects of remote ischemic preconditioning in rat hindlimb on ischemia- reperfusion injury. Neural Regen Res (2012) 0.77
Neuroimmune Response in Ischemic Preconditioning. Neurotherapeutics (2016) 0.77
Remote ischaemic conditioning-a new paradigm of self-protection in the brain. Nat Rev Neurol (2015) 0.77
Biological networks in ischemic tolerance - rethinking the approach to clinical conditioning. Transl Stroke Res (2013) 0.76
Effect of remote ischemic preconditioning on cognitive function after off-pump coronary artery bypass graft: a pilot study. Korean J Anesthesiol (2013) 0.76
Remote Ischemic Conditioning Alters Methylation and Expression of Cell Cycle Genes in Aneurysmal Subarachnoid Hemorrhage. Stroke (2015) 0.75
Remote ischemic preconditioning improves the cognitive function of elderly patients following colon surgery: A randomized clinical trial. Medicine (Baltimore) (2017) 0.75
Matched Cohort Analysis of the Effects of Limb Remote Ischemic Conditioning in Patients with Aneurysmal Subarachnoid Hemorrhage. Transl Stroke Res (2015) 0.75
Sleep Is Critical for Remote Preconditioning-Induced Neuroprotection. Sleep (2016) 0.75
Kidney remote ischemic preconditioning as a novel strategy to explore the accurate protective mechanisms underlying remote ischemic preconditioning. Interv Med Appl Sci (2017) 0.75
Remote Limb Preconditioning Generates a Neuroprotective Effect by Modulating the Extrinsic Apoptotic Pathway and TRAIL-Receptors Expression. Cell Mol Neurobiol (2016) 0.75
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci (2006) 4.51
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation (1993) 3.68
'Ischemic tolerance' phenomenon found in the brain. Brain Res (1990) 2.73
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res (1993) 2.20
Evaluation of rapid ischemic preconditioning in a rabbit model of spinal cord ischemia. Anesthesiology (2003) 1.56
Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation (1997) 1.51
Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab (1997) 1.50
Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest. Neurosci Lett (2006) 1.45
Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol (1997) 1.23
Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol (2002) 1.17
Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning. Basic Res Cardiol (2003) 1.15
Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia. J Bioenerg Biomembr (2004) 1.13
The role of extracellular signal-regulated kinases in the neuroprotection of limb ischemic preconditioning. Neurosci Res (2006) 1.12
Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp Biochem Physiol A Mol Integr Physiol (2006) 1.11
Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien) (2006) 1.05
Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res (1992) 1.02
Killer proteases and little strokes--how the things that do not kill you make you stronger. J Cereb Blood Flow Metab (2006) 0.96
Limb ischemic preconditioning attenuates apoptosis of pyramidal neurons in the CA1 hippocampus induced by cerebral ischemia-reperfusion in rats. Sheng Li Xue Bao (2004) 0.96
Ischemic preconditioning of the rat brain as a method of endothelial protection from ischemic/repercussion injury. Neurosci Behav Physiol (2005) 0.92
The role of nitric oxide in the neuroprotection of limb ischemic preconditioning in rats. Neurochem Res (2007) 0.89
[Protective effect of remote ischemic preconditioning against focal cerebral ischemia/reperfusion injury in rats]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2007) 0.82
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science (1997) 7.57
Identification and characterization of an IkappaB kinase. Cell (1997) 6.71
Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol (2001) 6.30
IRAK: a kinase associated with the interleukin-1 receptor. Science (1996) 5.32
Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet (1999) 4.55
Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA (1998) 4.36
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell (2001) 3.60
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55
HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
Stent placement for arterial and venous cerebrovascular disease: preliminary experience. Radiology (1994) 3.05
The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med (1994) 2.86
Nonconvulsive seizures are common in critically ill children. Neurology (2011) 2.77
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. J Neurosci (1998) 2.57
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill (2010) 2.49
Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49
Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev (2009) 2.49
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet (1998) 2.44
Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data. Am J Hum Genet (2001) 2.44
IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem (1999) 2.43
Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet (2000) 2.43
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Household exposure to passive cigarette smoking and serum micronutrient concentrations. Am J Clin Nutr (2000) 2.38
Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development (2001) 2.37
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35
Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. Proc Natl Acad Sci U S A (1993) 2.34
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest (2000) 2.32
Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med (1997) 2.30
Survival and complications in thalassemia. Ann N Y Acad Sci (2005) 2.25
The cell biology of osteoclast function. J Cell Sci (2000) 2.21
Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol (2008) 2.19
Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release (2001) 2.15
Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr (1997) 2.13
Clinical markers of early disease in persons near onset of Huntington's disease. Neurology (2001) 2.11
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure (1999) 2.09
Qualitative semi-parametric test for genetic associations in case-control designs under structured populations. Ann Hum Genet (2003) 2.07
Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med (2014) 2.06
A novel programed frameshift expresses the POL3 gene of retrotransposon Ty3 of yeast: frameshifting without tRNA slippage. Cell (1993) 2.00
Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther (2004) 1.97
Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer (2008) 1.97
Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol (1998) 1.94
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res (2000) 1.85
The human decatenation checkpoint. Proc Natl Acad Sci U S A (2001) 1.84
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84
Multiple classes of yeast mutants are defective in vacuole partitioning yet target vacuole proteins correctly. Mol Biol Cell (1996) 1.83
The influence of chronic disease on resource utilization in common acute pediatric conditions. Financial concerns for children's hospitals. Arch Pediatr Adolesc Med (1999) 1.77
CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci U S A (1995) 1.76
Crystallographic mapping of beta-lactams bound to a D-alanyl-D-alanine peptidase target enzyme. J Mol Biol (1989) 1.76
Methylation of thymine residues during oligonucleotide synthesis. Nucleic Acids Res (1985) 1.74
Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther (2000) 1.73
Hyperglycemia decreases acute neuronal ischemic changes after middle cerebral artery occlusion in cats. Stroke (1989) 1.73
Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res (1995) 1.72
The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nat Biotechnol (1998) 1.71
Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci U S A (1997) 1.67
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia (2008) 1.66
Extent and consistency across generations of linkage disequilibrium in commercial layer chicken breeding populations. Genetics (2005) 1.64
A new model for phenotypic suppression of frameshift mutations by mutant tRNAs. Mol Cell (1998) 1.63
The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem (2000) 1.62
Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet (1996) 1.59
Predictors of assistive technology abandonment. Assist Technol (1993) 1.59
Some views about the controversial dewetting morphology of polystyrene films. Eur Phys J E Soft Matter (2004) 1.57
Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke (1998) 1.57
A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A). Clin Chim Acta (1990) 1.57
Magnetic resonance imaging of the upper airway in children with Down syndrome. Am J Respir Crit Care Med (2001) 1.54
In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect Immun (1998) 1.50
Longitudinal evaluation of cardiopulmonary performance during exercise after bone marrow transplantation in children. J Pediatr (2000) 1.49
Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet (2000) 1.49
MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res (2001) 1.46
The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med (1997) 1.46
Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol (2000) 1.45
Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA (1996) 1.44
Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant (2011) 1.43
Computer algorithms for the automated measurement of retinal arteriolar diameters. Br J Ophthalmol (2001) 1.42
A dimeric DNA interface stabilized by stacked A.(G.G.G.G).A hexads and coordinated monovalent cations. J Mol Biol (2000) 1.42
Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res (2004) 1.42
Assembly and entry mechanisms of Semliki Forest virus. Arch Virol Suppl (1994) 1.42
Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol (2001) 1.42
Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol (2001) 1.42
Symptomatic Rathke's cleft cysts. Report of two cases. J Neurosurg (1982) 1.41
Intraoperative electrical stimulation for identification of cranial nerve nuclei. Muscle Nerve (1999) 1.41
Obesity is a risk factor for acute mountain sickness: a prospective study in Tibet railway construction workers on Tibetan plateau. Eur Rev Med Pharmacol Sci (2015) 1.41
Structural impact of hydrodynamic injection on mouse liver. Gene Ther (2006) 1.41
Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior. J Neurosci Res (2006) 1.39
TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol (2000) 1.38
Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol (2009) 1.37
Time of symptom onset of eight common medical emergencies. J Emerg Med (1995) 1.37
Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci (1996) 1.37
Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci U S A (1993) 1.36
Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China. Sex Transm Infect (2006) 1.34
Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice. Physiol Genomics (2000) 1.34
A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. Allergy (2009) 1.33
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci U S A (2000) 1.33
The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today (1999) 1.33